Cargando…
Early Lyme Borreliosis in Patients Treated with Tumour Necrosis Factor-Alfa Inhibitors
The study evaluated the course and outcome of erythema migrans in patients receiving tumour necrosis factor-alpha (TNF-α) inhibitors. Among 4157 adults diagnosed with erythema migrans in the period 2009–2018, 16 (2.6%) patients were receiving TNF-α inhibitors (adalimumab, infliximab, etarnecept, gol...
Autores principales: | Maraspin, Vera, Bogovič, Petra, Rojko, Tereza, Ogrinc, Katarina, Ružić-Sabljić, Eva, Strle, Franc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912410/ https://www.ncbi.nlm.nih.gov/pubmed/31684103 http://dx.doi.org/10.3390/jcm8111857 |
Ejemplares similares
-
Are Differences in Presentation of Early Lyme Borreliosis in Europe and North America a Consequence of a More Frequent Spirochetemia in American Patients?
por: Maraspin, Vera, et al.
Publicado: (2021) -
Lyme Borreliosis and Borrelia spielmanii
por: Maraspin, Vera, et al.
Publicado: (2006) -
Erythema Migrans: Course and Outcome in Patients Treated With Rituximab
por: Maraspin, Vera, et al.
Publicado: (2019) -
Characteristics of spirochetemic patients with a solitary erythema migrans skin lesion in Europe
por: Maraspin, Vera, et al.
Publicado: (2021) -
Colocalization of Radicular Pain and Erythema Migrans in Patients With Bannwarth Syndrome Suggests a Direct Spread of Borrelia Into the Central Nervous System
por: Ogrinc, Katarina, et al.
Publicado: (2021)